Early demand signals a shift toward flexible GLP-1 benefit models that help employers support employee access and transparent costs

GoodRx (Nasdaq: GDRX), the trusted platform for prescription access and affordability in the U.S., today announced the market-wide launch of its Employer Direct weight loss offering, giving employers a flexible way to help employees access and afford FDA-approved GLP-1 medications. As demand for these treatments grows, employers are looking for new ways to support access outside the traditional pharmacy benefit. Employer Direct allows employers to choose which medications to include and how much to contribute, giving them greater control over benefit costs while lowering what eligible employees pay out of pocket. Read More >